Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation-Reference-Cited by-同舟云学术

Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation

Published:2017-01 Issue: Volume:33 Page:195-198
ISSN:0899-9007
Container-title:Nutrition
language:en
Short-container-title:Nutrition

Author:

Kaido Toshimi,Tamai Yumiko,Hamaguchi Yuhei,Okumura Shinya,Kobayashi Atsushi,Shirai Hisaya,Yagi Shintaro,Kamo Naoko,Hammad Ahmed,Inagaki Nobuya,Uemoto Shinji

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism

Reference17 articles.

1. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People;Cruz-Jentoft;Age Ageing,2010

2. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia;Chen;J Am Med Dir Assoc,2014

3. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation;Kaido;Am J Transplant,2013

4. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation;Hamaguchi;Liver Transpl,2014

5. Sarcopenia and mortality after liver transplantation;Englesbe;J Am Coll Surg,2010

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Clinical Outcomes Using Left and Right Liver Grafts in Adult-to-adult Living-donor Liver Transplantation: A Retrospective Cohort Study Using the Korean Organ Transplantation Registry;Transplantation;2024-09-09

2. Navigating Cirrhosis: Presentation, Outcomes, and Treatments in Adulthood and Beyond;Current Treatment Options in Gastroenterology;2024-08-23

3. The impact of sarcopenia in the treatment for patients with head and neck cancer;Auris Nasus Larynx;2024-08

4. Neuromuscular electrical stimulation, muscle mass, and physical function decline in the early phase after living donor liver transplantation;Liver Transplantation;2024-05-28

5. Circulating myostatin levels as a prognostic biomarker in patients with acute liver failure and late‐onset hepatic failure;Hepatology Research;2024-04-24